Skip to main content

Day: January 18, 2022

GenTech’s FIZZIQUE™ Receives First Retail Orders from Top National Distributor UNFI™

$GTEH – GenTech’s FIZZIQUE™ Receives First Retail Orders from Top National Distributor UNFI™FIZZIQUE™ – The world’s first sparkling protein waterWheat Ridge, COLORADO, Jan. 18, 2022 (GLOBE NEWSWIRE) — GenTech Holdings, Inc. (OTC Pink: GTEH) (“GenTech” or the “Company”), (a/k/a Supplement Group (USA) Inc.,) (www.gentechholdings.com) an emerging leader in the Functional Food (www.sinfit.com) and Nutritional Supplement (www.americanmetabolix.com) marketplaces, received its first orders during the opening two weeks of 2022 from UNFI, North America’s largest publicly traded wholesale distributor of health and specialty foods, for its brand Fizzique™ (www.drinkfizzique.com) UNFI, a $20bn revenue company, supplies stores such as Whole Foods, with whom GenTech’s Nature Soothie™ already sells through, as well...

Continue reading

10 licences awarded in the Norwegian APA 2021 licensing round

Lundin Energy AB announces that its wholly owned subsidiary, Lundin Energy Norway AS (together Lundin Energy), has been awarded interests in a total of ten exploration licences in the 2021 Awards in Predefined Areas (APA) licensing round, in Norway. The award includes six licences in the North Sea, three licences in the Norwegian Sea and one licence in the Southern Barents Sea. Five of the newly awarded licences will be operated by Lundin Energy Norway. The licence interests are detailed below:LicenceBlocks WorkingInterest (Percent)Area1170* 7324/6,8,9, 7325/4,7 35% Southern Barents Sea1164* 6507/11 40% Norwegian Sea1162* 6407/2 50% Norwegian Sea1157* 6407/7 60% Norwegian Sea1152 33/3,5,6, 34/4 50% North Sea1147 29/9, 30/7,8,10,11 20% North Sea1142 25/4,5 9.05% North Sea1143 25/4,5 9.05% North Sea1139* 15/6 40% North...

Continue reading

ContinuServe Aligns 14 Service Providers Under M&A Consortium

CAMBRIDGE, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) — ContinuServe has announced a new M&A consortium of 14 partnering service providers that work together to deliver comprehensive, structured merger and acquisition (M&A) transaction services that individually would not be possible. ContinuServe’s M&A Consortium is working behind the scenes to bring forth a playbook of services among the providers that create efficiencies and streamline transactions. Each firm has a concerted focus on private equity and has proven solutions for M&A transactions. Consortium partners include ADP, ContinuServe, Fortium Partners, Globalization Partners, Lancor, Lockton, Oracle/NetSuite, Optimus, PMC Treasury, Risk International, Resourcive, Symphony and West Monroe. “By bringing together a holistic set of services to private equity...

Continue reading

Clarus Therapeutics Appoints Dr. Zhanna Jumadilova as Chief Clinical Development Officer

Dr. Jumadilova most recently led clinical development programs at Insmed and Pfizer and has nearly 30 years of combined pharmaceutical and biotech experience NORTHBROOK, Ill., Jan. 18, 2022 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, today announced the appointment of Zhanna Jumadilova, M.D., M.B.A., as Chief Clinical Development Officer, effective January 17, 2022. Dr. Jumadilova has nearly 30 years of experience in the pharmaceutical and biotech industries. She most recently led clinical development programs at Insmed and Pfizer. “Zhanna joins Clarus at a transformative time in our history as we further the clinical development of our pipeline assets,”...

Continue reading

Neovasc Announces Case Series of First U.S. Reducer Implants Published In Peer-Reviewed Journal

VANCOUVER and MINNEAPOLIS, Jan. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of a case series in the journal Cardiovascular Revascularization Medicine describing successful uses of the Neovasc Reducer™ (“Reducer”) under a compassionate use protocol in the United States. The patients were treated under the care of Ryan Gindi, M.D., and the procedures were performed by Gerald Koenig, M.D., Ph.D, both from the Division of Cardiology, Henry Ford Hospital, Detroit. Following the commencement of the COSIRA-II Trial in the United States, qualifying patients are now eligible to be treated in a clinical trial for the device. “We are pleased to publish the one-year outcomes of the first two patients treated with the Reducer device in the...

Continue reading

Monolithic Power Systems to Report Fourth Quarter and Full Year Results on February 10, 2022

KIRKLAND, Wash., Jan. 18, 2022 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (MPS) (Nasdaq: MPWR), a global company that provides high-performance, semiconductor-based power electronics solutions, today announced plans to report its financial results for the fourth quarter and year ended December 31, 2021. MPS will report its results after the market closes on Thursday, February 10th and host its quarterly conference at 2:00 p.m. PT / 5:00 p.m. ET. The live event will be held via a Zoom webinar, which can be accessed at https://mpsic.zoom.us/j/91891528185. A replay of the event will be available for one year under the Investor Relations website at www.monolithicpower.com two hours after the live event has concluded. About Monolithic Power Systems, Inc.Monolithic Power Systems, Inc. (MPS) is a global company that provides high-performance,...

Continue reading

Snowden To Join CFC as Senior Vice President

DULLES, Va., Jan. 18, 2022 (GLOBE NEWSWIRE) — The National Rural Utilities Cooperative Finance Corporation (CFC) announced today that Mark Snowden will join CFC’s executive team as a senior vice president focusing on strategic services for the electric cooperative network. Snowden currently serves as chief executive officer of Cimarron Electric Cooperative, based in Kingfisher, Oklahoma. “We are thrilled to have Mark join the CFC team. He brings extensive electric cooperative leadership and energy industry experience and a strong vision for the future,” CFC CEO Andrew Don said. In his leadership role, Snowden will work to ensure that CFC continues to provide best-in-class products and services to meet the needs of its electric utility members. “Mark’s experience and knowledge will assure that CFC continues to deliver business tools...

Continue reading

Leading Canadian Home Improvement Retailer Extends Fortinet Secure SD-WAN Across 1,100+ Network Edges

Fortinet Secure SD-WAN Enables Home Hardware to Enhance Business Critical Application Performance with Centralized Management SUNNYVALE, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) — Martin DeVries, Manager, Network & Telecommunications, Infrastructure & Security, Home Hardware Stores Limited“With approximately 1,100 locations and strict requirements for critical payment applications, our digital transformation efforts were no small undertaking. Fortinet Secure SD-WAN was the perfect fit for our organization, allowing us to simplify our network and enable our geographically distributed network of Dealers to access the applications they need with the same user experience across the organization. With our newfound capability to centrally manage all network traffic, we can now accelerate cloud access and ensure applications...

Continue reading

NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Chronic Chemotherapy Induced Peripheral Neuropathy (CIPN) with its Wearable Neurostimulation Technology

WOBURN, Mass., Jan. 18, 2022 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell® technology has received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for reducing moderate to severe symptoms of chemotherapy induced peripheral neuropathy that have persisted for at least 6-months following the end of chemotherapy. About 650,000 cancer patients receive chemotherapy annually in the United States. CIPN is a disabling complication that occurs in many patients treated with common chemotherapeutic drugs such as vincristine, paclitaxel and cisplatin. Symptoms include burning/shooting pain, tingling, cramping, and numbness in the hands and feet. CIPN is also associated with impaired balance, walking, and sleep, decreased quality of life, and increased risk of falls. Approximately...

Continue reading

LiveWire Ergogenics Appoints Brand Manager for Estrella River Farms and Estate Grown Weedery™ Family of Brands for Launch in 2022

Anaheim, CA, Jan. 18, 2022 (GLOBE NEWSWIRE) — LiveWire Ergogenics Inc. (OTC: LVVV), a company focused on acquiring, managing, and licensing special purpose real estate properties conducive to producing high-quality, handcrafted, and organically grown cannabis products for medical and recreational adult-use in California; today announced that it has appointed Thomas Elliot Fite as the brand manager for its portfolio of Estate Grown Weedery™ brands. As Brand Manager, Mr. Fite will focus on developing and building the Company’s parent brand, Estrella River Farms, and assisting with the marketing of affiliate brands aligned with the Company. Thomas brings the experience and skill set to establish and align effective strategies for building and maintaining solid brands in any marketplace with a broad range of knowledge in the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.